AppGenex Diagnostics, Inc. is a privately held Delaware Corporation founded in 2011 and located in Mountain View, CA.


The Company’s strategic focus is on the unmet diagnostic need of human diseases, such as tuberculosis (TB), affecting the developing world.


Institutions and accredited investors with interest in investing in AppGenex Diagnostics are encouraged to contact us for information on current investment opportunities.